Levothyroxine (Mercury Pharma) 50 mcg: Issue resolved
15 July 2022: We are advised that this supply issue is resolved.
Affected product
We have reached out to the supplier (BNM) who have let us know that the new shipment of levothyroxine 50 mcg (Pharmacode 2307766) has arrived in New Zealand.
On 15 June 2022, we have been advised that the product will be released to wholesalers on Thursday 16 June 2022. It should flow through to pharmacies from then.
We understand that existing stock levels have a very short expiry date and should only be dispensed when the use can be guaranteed before expiry.
BNM have also advised that they will credit pharmacies who have left over short dated stock.
Who to contact
Pharmacists should talk to their wholesalers about supply of levothyroxine.
We acknowledge the frustration this issue has caused for pharmacists and people who use levothyroxine. Unfortunately delays in the supply chain both nationally and internationally caused by COVID-19 have delayed the resupply of this product.